Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s diseaseTools Stöger, Reinhard, Scaife, Paula, Shephard, Freya and Chakrabarti, Lisa (2017) Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease. npj Parkinson's Disease, 3 (6). pp. 1-6. ISSN 2373-8057 Full text not available from this repository.
Official URL: http://www.nature.com/articles/s41531-017-0007-3
Abstract5-methylcytosine and the oxidation product 5-hydroxymethylcytosine are two prominent epigenetic variants of the cytosine base in nuclear DNA of mammalian brains. We measured levels of 5-methylcytosine and 5-hydroxymethylcytosine by enzyme-linked immunosorbent assay in DNA from post-mortem cerebella of individuals with Parkinson’s disease and age-matched controls. 5-methylcytosine levels showed no significant differences between Parkinson’s disease and control DNA sample sets. In contrast, median 5-hydroxymethylcytosine levels were almost twice as high (p < 0.001) in both male and female Parkinson’s disease individuals compared with controls. The distinct epigenetic profile identified in cerebellar DNA of Parkinson’s disease patients raises the question whether elevated 5-hydroxymethylcytosine levels are a driver or a consequence of Parkinson’s disease.
Actions (Archive Staff Only)
|
Tools
Tools
